When it comes to life-altering illnesses that necessitate an emergency room visit, many patients will want a second or third opinion in order to get the best and most efficient treatment available.
Enter Deep Breeze, a medical wonder from Israel with the potential to help both doctors and patients breathe easier about the way potentially serious lung conditions can be treated.
The company is one of a growing group of Israeli businesses geared to helping advance medicine through new technology, which is one of Israel's areas of expertise.
At the literal heart of Deep Breeze machinery is proprietary Vibration Response Imaging technology, which has enjoyed significant support among prominent members of the U.S. medical community.
Among them is Dr. Charles Pollack, chair, department of emergency medicine at Pennsylvania Hospital in Philadelphia, who has championed U.S. hospital use of Deep Breeze for the past three years.
Pollack is serving as one of the principal investigators for multi-disciplinary studies involving Deep Breeze and its potentially life-saving technology.
"Establishing an accurate diagnosis early on has a significant clinical and financial impact," explains Pollack. "The sooner the patient receives the right treatment, the better the outcomes potentially get.
"Early diagnosis will also help alleviate E.R. overcrowding through more efficient patient disposition. The non-invasive and radiation-free lung imaging system records lung sounds from sensors applied to a patient's back."
It's a business that combines math and science: " The system then uses sophisticated algorithms to convert data into images and quantitative regional lung information."
Dr. Igal Kushnir, the Israeli inventor and company founder, was a pediatrician serving patients in rural areas, and devised the Deep Breeze technology as a diagnostic tool for his young patients to reduce the amount of radiation they would be exposed to.
As time went on, he and his early adopters discovered that adults with various emergency respiratory health issues could benefit most from his invention's technology.
From that point forward, Deep Breeze has not only found its way into the United States, but also Canada, Spain, Italy, Greece, Turkey, Russia, China, Korea and India.
"VRI's functional imaging technology is very different from anatomical imaging, such as x-ray," explains David Barton, Deep Breeze USA's president and global vice president for marketing and business development.
The equipment "measures vibrations emanating from the lungs and processes data coming from those vibrations. This means that physicians can not only get a dynamic image of your lungs, but also quantification of what is happening inside of them.
Today, under the leadership of Michael Nagler at the company's Or Akiva, Israel headquarters, Deep Breeze continues to change the way patients with respiratory issues receive urgent care as well as address considerations such as cost-effectiveness and convenience for the patients and doctors alike.
"Beyond emergency room professionals, which Dr. Pollack is addressing through his research in Philadelphia, we are cultivating relationships with cardio-thoracic surgeons," says Nagler.
Though Barton acknowledges that some physicians are supporting Deep Breeze because of their desire to support an Israeli high-tech company, the overwhelming majority of doctors and their patients are most enthusiastic about how VRI technology can make treatment more efficient, cost-effective and safer, especially given the large variety of lung ailments it addresses.